½ÃÀ庸°í¼­
»óǰÄÚµå
1494880

¼¼°èÀÇ »ì¼­Á¦ ½ÃÀå ¿¹Ãø : À¯Çüº°, ¼³Ä¡·ù À¯Çüº°, Á¦Çüº°, ¿ëµµº°, Áö¿ªº° ºÐ¼®(-2030³â)

Rodenticides Market Forecasts to 2030 - Global Analysis By Type (Non-Anticoagulants and Anticoagulants), Rodent Type, Form, Application and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ »ì¼­Á¦ ½ÃÀåÀº 2024³â¿¡ 58¾ï ´Þ·¯·Î ÃßÁ¤µÇ°í, ¿¹Ãø ±â°£ µ¿¾È CAGR 7.9%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â 91¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù.

»ì¼­Á¦´Â Á㳪 Áã¿Í °°Àº ¼³Ä¡·ùÀÇ °³Ã¼¼ö¸¦ Á¦¾î, ¾ïÁ¦, Á¦°ÅÇϱâ À§ÇØ Æ¯º°È÷ Á¶Á¦µÈ È­ÇоàÁ¦ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¹°ÁúÀº Ç÷¾× ÀÀ°í¸¦ ¾ïÁ¦ÇÏ¿© ³»ÃâÇ÷À» ÀÏÀ¸Å°´Â Ç×ÀÀ°íÁ¦, Ä®½· ´ë»ç¸¦ ¾ïÁ¦Çϰųª Àå±â ºÎÀüÀ» ÀÏÀ¸Å°´Â ºñÇ×ÀÀ°íÁ¦ µî ´Ù¾çÇÑ ¸ÞÄ¿´ÏÁòÀ¸·Î ÀÛ¿ëÇÕ´Ï´Ù. »ì¼­Á¦´Â ³ó¾÷, µµ½Ã, ÁÖÅÿ¡¼­ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ¸ç, ³óÀÛ¹°À» º¸È£Çϰí, Áúº´ÀÇ Àü¿°À» ¹æÁöÇϰí, ½Äǰ °ø±ÞÀ» º¸È£ÇÔÀ¸·Î½á ÇØÃæ °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¹Ì±¹ Àα¸Á¶»ç±¹°ú ¹Ì±¹ ÁÖÅõµ½Ã°³¹ß¼º¿¡ µû¸£¸é 2020³â 2¿ù ½ÅÃà ´Üµ¶ÁÖÅà ÆÇ¸Å È£¼ö´Â 76¸¸ 5,000È£·Î, 2019³â 2¿ù ½ÅÃà ´Üµ¶ÁÖÅà ÆÇ¸Å È£¼ö´Â 66¸¸ 9,000È£¿´½À´Ï´Ù.

Áã ÇÇÇØ·Î ÀÎÇÑ °æÁ¦Àû ¹× ½Ä·® ¼Õ½Ç Áõ°¡

¼³Ä¡·ù¿¡ ÀÇÇÑ °æÁ¦Àû ºÎ´ãÀº ±â¾÷°ú °³ÀÎÀÌ ÀÌ·¯ÇÑ ¼Õ½ÇÀ» ¾ïÁ¦ÇÏ´Â ÇØ°áÃ¥¿¡ ÅõÀÚÇÏ´Â µ¿±âÀÔ´Ï´Ù. »ì¼­Á¦´Â ¼³Ä¡·ùÀÇ °³Ã¼¼ö¸¦ Á¦¾îÇÏ°í ³óÀÛ¹°À̳ª ÀúÀå½Äǰ, Àç»ê¿¡ ´ëÇÑ ÇÇÇØ¸¦ ¹æÁöÇϱâ À§ÇÑ °­·ÂÇÑ ¼ö´ÜÀÔ´Ï´Ù. ¼³Ä¡·ùÀÇ ¸¸¿¬¿¡ ÀÇÇÑ °æÁ¦Àû ¿µÇâÀÌ ¹àÇôÁü¿¡ µû¶ó, Áã¾àÀ» Æ÷ÇÔÇÑ È¿°úÀûÀÎ ¹æÁ¦ ¼ö´Ü¿¡ ´ëÇÑ ¼ö¿äµµ ºñ·ÊÇÏ¿© ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¾ö°ÝÇÑ ±ÔÁ¦ ¹× ±ÝÁö

¾ö°ÝÇÑ ±ÔÁ¦´Â »ì¼­Á¦¸¸Å­ È¿°úÀûÀÌ°í Æí¸®ÇÏÁö ¾ÊÀº ´ëü ¹æÁ¦ ¹æ¹ýÀ¸·Î ½ÃÀåÀ» ¹Ð¾î ¿Ã¸± ¼ö ÀÖ½À´Ï´Ù. Æ®·¦, Á¦°Å ±â¼ú ¹× ¼­½ÄÁöÀÇ °³¼±Àº »ì¼­Á¦¸¦ »ç¿ëÇÏ´Â °Í¿¡ ºñÇØ ½Ç½Ã¿¡ ¸¹Àº ³ë·Â°ú Àü¹® Áö½ÄÀÌ ÇÊ¿äÇϸç, ±ä ½ÂÀÎ ÇÁ·Î¼¼½º ¹× ±ÝÁö Á¶Ä¡ÀÇ °¡´É¼ºÀ¸·Î ÀÎÇØ ½ÅÁ¦Ç°ÀÇ ÅõÀÚ ¼öÀÍ·üÀÌ ºÒ·® È®½ÇÇϰí ÀÌ ºÐ¾ßÀÇ ±â¼ú Çõ½ÅÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ´ë¾ÈÀÇ È¿°úµµ »óȲ¿¡ µû¶ó ´Ù¸¦ ¼ö ÀÖ½À´Ï´Ù.

ÇØÃæ ¹æÁ¦ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

Çö´ëÀÇ ÇØÃæ Á¦°Å´Â ÃÖÀûÀÇ °á°ú¸¦ ¾ò±â À§ÇØ ¿©·¯ Ä¡·á ¹æ¹ýÀ» °áÇÕÇÏ´Â IPM Á¢±Ù¹ýÀ» »ç¿ëÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. »ì¼­Á¦´Â IPM Àü·«ÀÇ Áß¿äÇÑ ±¸¼º ¿ä¼ÒÀ̸ç Á¾Á¾ ÇÔÁ¤, Á¦°Å ±â¼ú ¹× ¼­½ÄÁö °³¼±°ú ÇÔ²² »ç¿ëµË´Ï´Ù. IPMÀÇ »ó½ÂÀº º¸´Ù ±¤¹üÀ§ÇÑ ÇØÃæ ¹æÁ¦ÀÇ Æ²¿¡¼­ »ì¼­Á¦ÀÇ ¿ªÇÒÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áã¾àÀÇ ¾ÈÀüÇϰí Ã¥ÀÓÀÖ´Â »ç¿ë¿¡ °üÇÑ Àü¹® Áö½ÄÀ» º¸¿©ÁÖ´Â ÇØÃæ ¹æÁ¦ ȸ»ç´Â °æÀï»ç¿Í Â÷º°È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. À̰ÍÀº °æÀïÀÌ ½ÉÇÑ ¾÷°è¿¡¼­´Â ±ÍÁßÇÑ ¸¶ÄÉÆÃ ¼ö´ÜÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

´ëü ¹æÁ¦ ¹æ¹ýÀÇ Áß½Ã

´ëü ¹æÁ¦ ¹æ¹ý¿¡ ´ëÇÑ ÁÖ¸ñÀÌ ³ô¾ÆÁüÀ¸·Î½á, »ì¼­Á¦´Â ´õ ÀÌ»ó ÇÊ¿ä¾ø°í, È¿°úÀûÀÌÁö ¾Ê´Ù´Â ÀνÄÀÌ Å¾Áöµµ ¸ð¸¨´Ï´Ù. À̰ÍÀº ƯÈ÷ ´ëü ¹æ¹ýÀÌ Á¦´ë·Î ±¸ÇöµÇÁö ¾Ê¾Ò°Å³ª ¸ðµç »óȲ¿¡ ÀûÇÕÇÏÁö ¾ÊÀº °æ¿ì¿¡ ¹®Á¦°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. »ì¼­Á¦´Â ´ë±Ô¸ð È®»êÀ» ½Å¼ÓÇÏ°Ô ¹æÁ¦ÇÏ´Â °­·ÂÇÑ ¼ö´ÜÀÌ µÉ ¼ö ÀÖÁö¸¸ Æ®·¦°ú Á¦°Å ±â¼úÀÌ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

óÀ½¿¡´Â °ø±Þ¸ÁÀÇ È¥¶õ°ú °æÁ¦ Ȱµ¿ÀÇ ÀúÇÏ·Î ÀÎÇØ ƯÈ÷ Á¢°´¾÷ ¹× »ó¾÷½Ã¼³ µîÀÇ ºÐ¾ß¿¡¼­ »ì¼­Á¦ ¼ö¿ä°¡ °¨¼ÒÇß½À´Ï´Ù. ±×·¯³ª µµ½Ã¿¡¼­´Â ´Ü´ÜÈ÷ Á¶ÀÌ´Â µ¿¾È ÁãÀÇ È°µ¿ÀÌ È°¹ßÇØÁ® À§»ý»óÀÇ ¿ì·Á°¡ ³ô¾ÆÁø °Íµµ ÇÔ²², ÁÖÅÃȯ°æ¿¡ À־ÀÇ »ì¼­Á¦ ¼ö¿ä¿¡ ¹ÚÂ÷°¡ °É·È½À´Ï´Ù. ¶ÇÇÑ, ÆÒµ¥¹Í¿¡ ´ëÀÀÇÏ¿© ½ÄǰÀÇ ¾ÈÀü¼º°ú À§»ýÀ» Áß½ÃÇÏ°Ô µÊÀ¸·Î½á, ³ó¾÷À̳ª ½Äǰ °¡°ø µî ÀϺΠ¾÷°è¿¡¼­´Â Áã ±¸Á¦ ´ëÃ¥¿¡ ÅõÀÚÇϵµ·Ï µÇ¾ú½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ºñÇ×ÀÀ°íÁ¦ ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ °ÍÀ¸·Î ¿¹»ó

¿¹Ãø ±â°£ µ¿¾È ºñÇ×ÀÀ°íÁ¦°¡ ÃÖ´ë°¡ µÉ Àü¸ÁÀÔ´Ï´Ù. ºê·Î¸ÞÅ»¸°°ú °°Àº ½Å°æµ¶, ºñŸ¹Î D3(ÄÝ·¹Ä®½ÃÆä·Ñ), ÀÎÈ­ ¾Æ¿¬À» Æ÷ÇÔÇÑ ºñÇ×ÀÀ°íÁ¦´Â ±âÁ¸ÀÇ Ç×ÀÀ°íÁ¦¿Í ºñ±³ÇÏ¿© ´õ ºü¸¥ ÀÛ¿ë ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ´ë¾ÈÀº ¼³Ä¡·ù °³Ã¼±º ³»¼º¿¡ ´ëÇÑ ¿ì·Á¸¦ ÇØ°áÇÏ°í ¹Ý·Áµ¿¹°°ú ¾ß»ýµ¿¹°À» Æ÷ÇÔÇÑ ºñÇ¥Àû Á¾¿¡¼­ 2Â÷ Áßµ¶ÀÇ À§ÇèÀ» ÁÙÀ̴µ¥, ÀÌ´Â Å« ÀÌÁ¡ÀÔ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È CAGRÀÌ °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹»óµÇ´Â °ÍÀº ºÐ¸» ºÎ¹®

ºÐ¸» ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È CAGRÀÌ °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿Ö³ÄÇÏ¸é °¡·ç´Â Á¾Á¾ ¸ÕÁö·Î »ìÆ÷µÇ¾î Áã ¸ðÇÇ¿¡ ºÙ¾î ÅÐÀÌ ¹¯¾îÀÖ´Â µ¿¾È ¼·ÃëµÇ±â ¶§¹®¿¡ ÃÖ¼ÒÇÑÀÇ º£ÀÌÆ® ¼Òºñ·®¿¡¼­µµ ³ôÀº È¿°ú¸¦ È®º¸ ÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ ÀÛ¿ë ¹æ½ÄÀº ¹Ì³¢ »þÀÌ¿¡ ´ëóÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç ±âÁ¸ÀÇ ¹Ì³¢ Á¦Á¦¿¡ ÀúÇ×ÇÏ´Â ¼³Ä¡·ù °³Ã¼±ºÀÇ Ä¡·á¸¦ °­È­ÇÕ´Ï´Ù. ÆÄ¿ì´õ´Â ÀüÅëÀûÀÎ ¹Ì³¢ ¹× ÇÔÁ¤¿¡¼­ Á㸦 Á¦°ÅÇϱ⠾î·Á¿î º®ÀÇ °øµ¿À̳ª ´Ù¶ô¹æ°ú °°Àº ¼ÕÀÌ ´êÁö ¾Ê´Â °÷¿¡¼­ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ¶ÇÇÑ Ä§ÀÔÀÌ Àû°í ±ú²ýÇÏ°Ô »ç¿ëÇÒ ¼ö ÀÖÀ¸¹Ç·Î ÁÖÅðú »ó¾÷½Ã¼³ ¸ðµÎ¿¡ ÀûÇÕÇÕ´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª :

ºÏ¹Ì¿¡´Â ´Ù¼öÀÇ Á¦Á¶¾÷ü°¡ Á¸ÀçÇϰí, À§»ý ¼öÁصµ ³ô±â ¶§¹®¿¡ ¿¹Ãø ±â°£Áß, ºÏ¹Ì°¡ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¾î, ºÏ¹ÌÀÇ »ì¼­Á¦ ¼ö¿ä¸¦ °ßÀÎÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â °³Ãà°ú Çö´ëÈ­ Ȱµ¿À¸·Î ¿À·¡µÈ °Ç¹°¿¡¼­ ´ë·®ÀÇ Áã°¡ ÂѰܳª°í, ±× Áã°¡ ½Ã°¡Áö·Î È®»êµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀÌ ÀÌ Áö¿ªÀÇ »ê¾÷ ¼ºÀåÀ» ¾ÕÀ¸·Î ¼ö³â°£ °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

¾Æ½Ã¾ÆÅÂÆò¾çÀº Áß±¹, Àεµ, ÀϺ», Çѱ¹ µî ½ÅÈï ±¹°¡µéÀÌ ÀÚ±¹»ê¾÷ÀÇ ¹ßÀü°ú ÀÌ¿¡ µû¸¥ ¼öÃâ °¡¼Ó, ¾ö°ÝÇÑ ±âÁØ µµÀÔ, ±Þ¼ÓÇÑ µµ½ÃÈ­¸¦ ÅëÇØ ¸Å·ÂÀûÀÎ ½ÃÀåÀÌ µÇ°í Àֱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Áß±¹°ú °°Àº ½ÅÈï ½ÃÀåÀº µ¶Æ¯ÇÑ »ê¾÷ÀÇ ¹ßÀü°ú ¼öÃâÀÇ °¡¼ÓÈ­, ¾ö°ÝÇÑ ±âÁØÀÇ µµÀÔ, ±Þ¼ÓÇÑ µµ½ÃÈ­¸¦ ÅëÇØ ¸Å·ÂÀûÀÎ Àå¼Ò°¡ µÇ°í ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃã¼³Á¤ ¼­ºñ½º :

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ Á¦°øÇÕ´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå Ãß°è, ¿¹Ãø ¹× CAGR(ÁÖ : Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç ¹× Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç Á¤º¸¿ø
    • 1Â÷ Á¶»ç Á¤º¸¿ø
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÀÔ¾÷ÀÚÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ »ì¼­Á¦ ½ÃÀå : À¯Çüº°

  • ºñÇ×ÀÀ°íÁ¦
  • Ç×ÀÀ°íÁ¦

Á¦6Àå ¼¼°èÀÇ »ì¼­Á¦ ½ÃÀå : ¼³Ä¡·ù À¯Çüº°

  • Áã
  • ¸¶¿ì½º
  • ´Ù¶÷Áã
  • ±âŸ ¼³Ä¡·ù

Á¦7Àå ¼¼°èÀÇ »ì¼­Á¦ ½ÃÀå : Çüź°

  • ºí·Ï
  • Æç·¿
  • ºÐ¸»
  • ¾×ü
  • °ú¸³

Á¦8Àå ¼¼°èÀÇ »ì¼­Á¦ ½ÃÀå : ¿ëµµº°

  • â°í
  • ³ó¾÷ ºÐ¾ß
  • µµ½Ã Á߽ɺÎ
  • °¡Á¤ ¹× ÁÖÅÃ
  • »ê¾÷
  • ±âŸ ¿ëµµ

Á¦9Àå ¼¼°èÀÇ »ì¼­Á¦ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷ ¹× ÇÕÀÛ ÅõÀÚ
  • Àμö ¹× ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Babolna Bio
  • BASF SE
  • Bayer AG
  • Bell Laboratories, Inc.
  • Brodifacoum
  • ECOCLEAR Products
  • Impex Europa
  • JT Eaton & Co., Inc.
  • Kollant srl
  • Liphatech, Inc.
  • Neogen Corporation
  • PelGar International Ltd
  • Reckitt Benckiser Group plc
  • Rentokil Initial plc
  • Russell IPM Ltd
  • SenesTech, Inc.
  • Syngenta AG
  • UPL Limited
AJY 24.06.25

According to Stratistics MRC, the Global Rodenticides Market is accounted for $5.8 billion in 2024 and is expected to reach $9.1 billion by 2030 growing at a CAGR of 7.9% during the forecast period. Rodenticides are chemical agents specifically formulated to control, deter, or eliminate rodent populations such as rats and mice. These substances work through various mechanisms, including anticoagulants, which inhibit blood clotting and cause internal bleeding, and non-anticoagulants, which may act through mechanisms such as disrupting calcium metabolism or causing organ failure. Commonly used in agricultural, urban, and residential settings, rodenticides play a crucial role in pest management by protecting crops, preventing disease transmission, and safeguarding food supplies.

According to the U.S. Census Bureau and the U.S. Department of Housing and Urban Development, 765,000 new houses were sold in February 2020, as compared to 669,000 new single-family houses in February 2019.

Market Dynamics:

Driver:

Rising economic and food losses from rodent damage

The economic burden caused by rodents incentivizes businesses and individuals to invest in solutions to curb these losses. Rodenticides offer a powerful tool for controlling rodent populations and preventing damage to crops, stored food, and property. As the financial impact of rodent infestations becomes more evident, the demand for effective control measures, including rodenticides, rises proportionally.

Restraint:

Stringent regulations and bans

Stringent regulations can push the market towards alternative control methods, which may not always be as effective or convenient as rodenticides. Traps, exclusion techniques, and habitat modification require more effort and expertise to implement compared to using rodenticides and the lengthy approval processes and potential for bans can make the return on investment for new products uncertain, hindering innovation in the field. The effectiveness of these alternatives can also vary depending on the situation.

Opportunity:

Increasing demand for pest control services

Modern pest control often utilizes an IPM approach, which combines multiple control methods for optimal results. Rodenticides are a key component of IPM strategies, often used alongside traps, exclusion techniques, and habitat modification. The rise of IPM strengthens the role of rodenticides within a broader pest control framework. Moreover Pest control companies that demonstrate expertise in the safe and responsible use of rodenticides can differentiate themselves from competitors. This can be a valuable marketing tool in a competitive industry.

Threat:

Focus on alternative control methods

Increased focus on alternatives might create a perception that rodenticides are no longer necessary or effective. This could be particularly problematic if alternative methods are not properly implemented or suited for all situations. Rodenticides can be a powerful tool for rapid control of large infestations, something that traps and exclusion techniques may struggle with hampering the growth of the market.

Covid-19 Impact

Initially, disruptions in supply chains and decreased economic activity led to reduced demand for rodenticides, particularly in sectors like hospitality and commercial establishments. However, increased rodent activity in urban areas during lockdowns, coupled with heightened hygiene concerns, spurred demand for rodenticides in residential settings. Additionally, the emphasis on food safety and sanitation in response to the pandemic has prompted some industries, such as agriculture and food processing, to invest in rodent control measures.

The non-anticoagulants segment is expected to be the largest during the forecast period

The non-anticoagulants is expected to be the largest during the forecast period. Non-anticoagulants, including neurotoxins like bromethalin, vitamin D3 (cholecalciferol), and zinc phosphide, offer a faster mode of action compared to traditional anticoagulants. These alternatives address concerns about resistance in rodent populations and reduce the risk of secondary poisoning in non-target species, including pets and wildlife, which is a significant advantage.

The powders segment is expected to have the highest CAGR during the forecast period

The powders segment is expected to have the highest CAGR during the forecast period because these powders, often applied as dusts, adhere to rodents' fur and are ingested during grooming, ensuring higher efficacy even with minimal bait consumption. This mode of action helps address bait shyness and enhances the control of rodent populations resistant to traditional bait forms. Powders are particularly useful in hard-to-reach areas, such as wall voids and attics, where rodents are difficult to control with conventional baits or traps. Moreover, they offer a less intrusive and cleaner application, which is attractive for both residential and commercial settings.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the presence of a large number of manufacturers, coupled with high standards of hygiene, is likely to drive the demand for rodenticides in North America over the forecast period. Renovation and modernization activities in this region have resulted in the displacement of a large number of rats from old buildings, which then disperse into the city. Such factors are expected to drive the growth of the regional industry in the coming years.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to emerging markets in countries such as China, India, Japan, and South Korea, which have become attractive through the development of indigenous industries and subsequent acceleration in exports, the introduction of stringent standards, and rapid urbanization. Emerging markets, such as China, have become attractive spots through developing indigenous industries and subsequent acceleration in exports, the introduction of stringent standards, and rapid urbanization.

Key players in the market

Some of the key players in Rodenticides market include Babolna Bio, BASF SE, Bayer AG, Bell Laboratories, Inc., Brodifacoum, ECOCLEAR Products, Impex Europa, JT Eaton & Co., Inc., Kollant s.r.l., Liphatech, Inc., Neogen Corporation, PelGar International Ltd, Reckitt Benckiser Group plc, Rentokil Initial plc, Russell IPM Ltd, SenesTech, Inc., Syngenta AG and UPL Limited

Key Developments:

In May 2024, BASF expands its biomass balance portfolio for selected chemical intermediates. With these certifications, BASF can now offer its customers regionally produced ISCC PLUS and REDcert2-certified products for which renewable resources replace fossil feedstock

In May 2024, BASF now offers first biomass-balanced products for its ammonia and urea portfolio. The wide range of products includes ammonia anhydrous BMBcertTM, ammonia solution 24.5% BMBcertTM, urea prills BMBcertTM, urea solution 40% BMBcertTM, and urea solution 45% BMBcertTM.

In May 2024, Bayer to present real-world study data of Kerendia(TM) (finerenone) use and risk models for the progression of chronic kidney disease and onset of hyperkalaemia. The data will include insights on how finerenone is used with other renal and cardiovascular protective medicines, and modelling

Types Covered:

  • Non-Anticoagulants
  • Anticoagulants

Rodent Types Covered:

  • Rats
  • Mice
  • Squirrels
  • Other Rodent Types

Forms Covered:

  • Blocks
  • Pellets
  • Powders
  • Liquids
  • Granules

Applications Covered:

  • Warehouses
  • Agricultural Fields
  • Urban Centers
  • Domestic/Household
  • Industrial
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Rodenticides Market, By Type

  • 5.1 Introduction
  • 5.2 Non-Anticoagulants
  • 5.3 Anticoagulants

6 Global Rodenticides Market, By Rodent Type

  • 6.1 Introduction
  • 6.2 Rats
  • 6.3 Mice
  • 6.4 Squirrels
  • 6.5 Other Rodent Types

7 Global Rodenticides Market, By Form

  • 7.1 Introduction
  • 7.2 Blocks
  • 7.3 Pellets
  • 7.4 Powders
  • 7.5 Liquids
  • 7.6 Granules

8 Global Rodenticides Market, By Application

  • 8.1 Introduction
  • 8.2 Warehouses
  • 8.3 Agricultural Fields
  • 8.4 Urban Centers
  • 8.5 Domestic/Household
  • 8.6 Industrial
  • 8.7 Other Applications

9 Global Rodenticides Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Babolna Bio
  • 11.2 BASF SE
  • 11.3 Bayer AG
  • 11.4 Bell Laboratories, Inc.
  • 11.5 Brodifacoum
  • 11.6 ECOCLEAR Products
  • 11.7 Impex Europa
  • 11.8 JT Eaton & Co., Inc.
  • 11.9 Kollant s.r.l.
  • 11.10 Liphatech, Inc.
  • 11.11 Neogen Corporation
  • 11.12 PelGar International Ltd
  • 11.13 Reckitt Benckiser Group plc
  • 11.14 Rentokil Initial plc
  • 11.15 Russell IPM Ltd
  • 11.16 SenesTech, Inc.
  • 11.17 Syngenta AG
  • 11.18 UPL Limited
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦